Summary
A 22-year-old recent college graduate was denied a security clearance under Guideline E (Personal Conduct) and Guideline H (Drug Involvement) due to marijuana use and inconsistent statements regarding that use. The Statement of Reasons alleged that the applicant used marijuana from approximately 2005 until at least August 2008, including after being granted a Department of Defense security clearance in about September 2006.
Further allegations stated that the applicant deliberately falsified a May 26, 2006, Questionnaire for National Security Positions by denying any illegal drug use since age 16 or within the last seven years. Additionally, marijuana and drug paraphernalia were found in his car during a police search in about August 2008.
The denial was based on the applicant's repeated marijuana use after receiving a security clearance, which raised concerns about his reliability and trustworthiness. His credibility was undermined by discrepant accounts of his drug involvement, and he failed to provide truthful information on his e-QIP regarding his drug use. The judge concluded that the applicant's conduct raised significant doubts about his judgment and reliability.
Why the Applicant Was Denied
- The applicant smoked marijuana on multiple occasions after being granted a security clearance, raising concerns about his reliability and trustworthiness.
- Discrepant accounts regarding the extent of his drug involvement undermined his credibility.
- The applicant failed to provide truthful information on his e-QIP regarding his drug use.
Conditions Referenced
- AG ¶ 24raisedDrug Involvement
- AG ¶ 15raisedPersonal Conduct
Key Rule Quoted
“The protection of the national security is the paramount consideration.”
Procedural Posture
- SOR issuedSep 25, 2009
- Answer filedOct 16, 2009
- Hearing heldDec 16, 2009
- Decision dateApr 7, 2010
Cite For
- Discrepancies in Applicant's Accounts of Drug Use Affecting Credibility
- Impact of Drug Use on Security Clearance Eligibility
- Failure to Disclose Drug Use on E-qip as a Basis for Denial Under Guideline E